 | • レポートコード：D0GIR-00274 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、無針糖尿病ケアの世界市場を広く調査・分析し、今後の市場展望をまとめております。無針糖尿病ケアの種類別市場規模（インスリンパッチ、ジェットインジェクター、インスリンペン、インスリンポンプ、インスリン注入器）、用途別市場規模（消費者、診断センター、病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Antares Pharma、Injex UK、European Pharma Group、Johnson and Johnson、MannKind Corporation、Echo Therapeutics ・地域別グローバル市場分析 2015年-2020年 ・無針糖尿病ケアの北米市場（アメリカ、カナダ、メキシコ） ・無針糖尿病ケアのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・無針糖尿病ケアのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・無針糖尿病ケアの南米市場（ブラジル、アルゼンチン） ・無針糖尿病ケアの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：インスリンパッチ、ジェットインジェクター、インスリンペン、インスリンポンプ、インスリン注入器 ・用途別分析：消費者、診断センター、病院、クリニック ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Needle-Free Diabetes Care market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Needle-Free Diabetes Care market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Needle-Free Diabetes Care market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Needle-Free Diabetes Care market has been segmented into:
Insulin Patches
Jet Injectors
Insulin Pens
Insulin Pumps
Insulin Infuser
By Application, Needle-Free Diabetes Care has been segmented into:
Consumer
Diagnostic Centers
Hospitals and Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Needle-Free Diabetes Care market presented in the report. This section sheds light on the sales growth of different regional and country-level Needle-Free Diabetes Care markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Needle-Free Diabetes Care market.
The report offers in-depth assessment of the growth and other aspects of the Needle-Free Diabetes Care market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Needle-Free Diabetes Care Market Share Analysis
Needle-Free Diabetes Care competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Needle-Free Diabetes Care sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Needle-Free Diabetes Care sales, revenue and market share for each player covered in this report.
The major players covered in Needle-Free Diabetes Care are:
Antares Pharma
Injex UK
European Pharma Group
Johnson and Johnson
MannKind Corporation
Echo Therapeutics
Table of Contents
1 Needle-Free Diabetes Care Market Overview
1.1 Product Overview and Scope of Needle-Free Diabetes Care
1.2 Classification of Needle-Free Diabetes Care by Type
1.2.1 Global Needle-Free Diabetes Care Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Needle-Free Diabetes Care Revenue Market Share by Type in 2019
1.2.3 Insulin Patches
1.2.4 Jet Injectors
1.2.5 Insulin Pens
1.2.6 Insulin Pumps
1.2.7 Insulin Infuser
1.3 Global Needle-Free Diabetes Care Market by Application
1.3.1 Overview: Global Needle-Free Diabetes Care Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Consumer
1.3.3 Diagnostic Centers
1.3.4 Hospitals and Clinics
1.4 Global Needle-Free Diabetes Care Market by Regions
1.4.1 Global Needle-Free Diabetes Care Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Needle-Free Diabetes Care (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Needle-Free Diabetes Care Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Needle-Free Diabetes Care Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Needle-Free Diabetes Care Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Needle-Free Diabetes Care Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Needle-Free Diabetes Care Status and Prospect (2015-2025)
2 Company Profiles
2.1 Antares Pharma
2.1.1 Antares Pharma Details
2.1.2 Antares Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Antares Pharma SWOT Analysis
2.1.4 Antares Pharma Product and Services
2.1.5 Antares Pharma Needle-Free Diabetes Care Revenue, Gross Margin and Market Share (2018-2019)
2.2 Injex UK
2.2.1 Injex UK Details
2.2.2 Injex UK Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Injex UK SWOT Analysis
2.2.4 Injex UK Product and Services
2.2.5 Injex UK Needle-Free Diabetes Care Revenue, Gross Margin and Market Share (2018-2019)
2.3 European Pharma Group
2.3.1 European Pharma Group Details
2.3.2 European Pharma Group Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 European Pharma Group SWOT Analysis
2.3.4 European Pharma Group Product and Services
2.3.5 European Pharma Group Needle-Free Diabetes Care Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson and Johnson
2.4.1 Johnson and Johnson Details
2.4.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson and Johnson SWOT Analysis
2.4.4 Johnson and Johnson Product and Services
2.4.5 Johnson and Johnson Needle-Free Diabetes Care Revenue, Gross Margin and Market Share (2018-2019)
2.5 MannKind Corporation
2.5.1 MannKind Corporation Details
2.5.2 MannKind Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 MannKind Corporation SWOT Analysis
2.5.4 MannKind Corporation Product and Services
2.5.5 MannKind Corporation Needle-Free Diabetes Care Revenue, Gross Margin and Market Share (2018-2019)
2.6 Echo Therapeutics
2.6.1 Echo Therapeutics Details
2.6.2 Echo Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Echo Therapeutics SWOT Analysis
2.6.4 Echo Therapeutics Product and Services
2.6.5 Echo Therapeutics Needle-Free Diabetes Care Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Needle-Free Diabetes Care Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Needle-Free Diabetes Care Players Market Share
3.2.2 Top 10 Needle-Free Diabetes Care Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Needle-Free Diabetes Care Revenue and Market Share by Regions
4.2 North America Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
4.3 Europe Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
4.5 South America Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
5 North America Needle-Free Diabetes Care Revenue by Countries
5.1 North America Needle-Free Diabetes Care Revenue by Countries (2015-2020)
5.2 USA Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
5.3 Canada Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
5.4 Mexico Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
6 Europe Needle-Free Diabetes Care Revenue by Countries
6.1 Europe Needle-Free Diabetes Care Revenue by Countries (2015-2020)
6.2 Germany Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
6.3 UK Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
6.4 France Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
6.5 Russia Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
6.6 Italy Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Needle-Free Diabetes Care Revenue by Countries
7.1 Asia-Pacific Needle-Free Diabetes Care Revenue by Countries (2015-2020)
7.2 China Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
7.3 Japan Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
7.4 Korea Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
7.5 India Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
8 South America Needle-Free Diabetes Care Revenue by Countries
8.1 South America Needle-Free Diabetes Care Revenue by Countries (2015-2020)
8.2 Brazil Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
8.3 Argentina Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Needle-Free Diabetes Care by Countries
9.1 Middle East & Africa Needle-Free Diabetes Care Revenue by Countries (2015-2020)
9.2 Saudi Arabia Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
9.3 UAE Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
9.4 Egypt Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
9.5 South Africa Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Needle-Free Diabetes Care Revenue and Market Share by Type (2015-2020)
10.2 Global Needle-Free Diabetes Care Market Forecast by Type (2019-2024)
10.3 Insulin Patches Revenue Growth Rate (2015-2025)
10.4 Jet Injectors Revenue Growth Rate (2015-2025)
10.5 Insulin Pens Revenue Growth Rate (2015-2025)
10.6 Insulin Pumps Revenue Growth Rate (2015-2025)
10.7 Insulin Infuser Revenue Growth Rate (2015-2025)
11 Global Needle-Free Diabetes Care Market Segment by Application
11.1 Global Needle-Free Diabetes Care Revenue Market Share by Application (2015-2020)
11.2 Needle-Free Diabetes Care Market Forecast by Application (2019-2024)
11.3 Consumer Revenue Growth (2015-2020)
11.4 Diagnostic Centers Revenue Growth (2015-2020)
11.5 Hospitals and Clinics Revenue Growth (2015-2020)
12 Global Needle-Free Diabetes Care Market Size Forecast (2021-2025)
12.1 Global Needle-Free Diabetes Care Market Size Forecast (2021-2025)
12.2 Global Needle-Free Diabetes Care Market Forecast by Regions (2021-2025)
12.3 North America Needle-Free Diabetes Care Revenue Market Forecast (2021-2025)
12.4 Europe Needle-Free Diabetes Care Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Needle-Free Diabetes Care Revenue Market Forecast (2021-2025)
12.6 South America Needle-Free Diabetes Care Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Needle-Free Diabetes Care Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Needle-Free Diabetes Care Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Needle-Free Diabetes Care by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Needle-Free Diabetes Care Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Needle-Free Diabetes Care Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Antares Pharma Corporate Information, Location and Competitors
Table 6. Antares Pharma Needle-Free Diabetes Care Major Business
Table 7. Antares Pharma Needle-Free Diabetes Care Total Revenue (USD Million) (2017-2018)
Table 8. Antares Pharma SWOT Analysis
Table 9. Antares Pharma Needle-Free Diabetes Care Product and Solutions
Table 10. Antares Pharma Needle-Free Diabetes Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Injex UK Corporate Information, Location and Competitors
Table 12. Injex UK Needle-Free Diabetes Care Major Business
Table 13. Injex UK Needle-Free Diabetes Care Total Revenue (USD Million) (2018-2019)
Table 14. Injex UK SWOT Analysis
Table 15. Injex UK Needle-Free Diabetes Care Product and Solutions
Table 16. Injex UK Needle-Free Diabetes Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. European Pharma Group Corporate Information, Location and Competitors
Table 18. European Pharma Group Needle-Free Diabetes Care Major Business
Table 19. European Pharma Group Needle-Free Diabetes Care Total Revenue (USD Million) (2017-2018)
Table 20. European Pharma Group SWOT Analysis
Table 21. European Pharma Group Needle-Free Diabetes Care Product and Solutions
Table 22. European Pharma Group Needle-Free Diabetes Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Johnson and Johnson Corporate Information, Location and Competitors
Table 24. Johnson and Johnson Needle-Free Diabetes Care Major Business
Table 25. Johnson and Johnson Needle-Free Diabetes Care Total Revenue (USD Million) (2017-2018)
Table 26. Johnson and Johnson SWOT Analysis
Table 27. Johnson and Johnson Needle-Free Diabetes Care Product and Solutions
Table 28. Johnson and Johnson Needle-Free Diabetes Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. MannKind Corporation Corporate Information, Location and Competitors
Table 30. MannKind Corporation Needle-Free Diabetes Care Major Business
Table 31. MannKind Corporation Needle-Free Diabetes Care Total Revenue (USD Million) (2017-2018)
Table 32. MannKind Corporation SWOT Analysis
Table 33. MannKind Corporation Needle-Free Diabetes Care Product and Solutions
Table 34. MannKind Corporation Needle-Free Diabetes Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Echo Therapeutics Corporate Information, Location and Competitors
Table 36. Echo Therapeutics Needle-Free Diabetes Care Major Business
Table 37. Echo Therapeutics Needle-Free Diabetes Care Total Revenue (USD Million) (2017-2018)
Table 38. Echo Therapeutics SWOT Analysis
Table 39. Echo Therapeutics Needle-Free Diabetes Care Product and Solutions
Table 40. Echo Therapeutics Needle-Free Diabetes Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Needle-Free Diabetes Care Revenue (Million USD) by Players (2015-2020)
Table 42. Global Needle-Free Diabetes Care Revenue Share by Players (2015-2020)
Table 43. Global Needle-Free Diabetes Care Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Needle-Free Diabetes Care Revenue Market Share by Regions (2015-2020)
Table 45. North America Needle-Free Diabetes Care Revenue by Countries (2015-2020)
Table 46. North America Needle-Free Diabetes Care Revenue Market Share by Countries (2015-2020)
Table 47. Europe Needle-Free Diabetes Care Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Needle-Free Diabetes Care Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Needle-Free Diabetes Care Revenue by Countries (2015-2020)
Table 50. South America Needle-Free Diabetes Care Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Needle-Free Diabetes Care Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Needle-Free Diabetes Care Revenue Market Share by Countries (2015-2020)
Table 53. Global Needle-Free Diabetes Care Revenue (Million USD) by Type (2015-2020)
Table 54. Global Needle-Free Diabetes Care Revenue Share by Type (2015-2020)
Table 55. Global Needle-Free Diabetes Care Revenue Forecast by Type (2021-2025)
Table 56. Global Needle-Free Diabetes Care Revenue by Application (2015-2020)
Table 57. Global Needle-Free Diabetes Care Revenue Share by Application (2015-2020)
Table 58. Global Needle-Free Diabetes Care Revenue Forecast by Application (2021-2025)
Table 59. Global Needle-Free Diabetes Care Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Needle-Free Diabetes Care Picture
Figure 2. Global Needle-Free Diabetes Care Revenue Market Share by Type in 2019
Figure 3. Insulin Patches Picture
Figure 4. Jet Injectors Picture
Figure 5. Insulin Pens Picture
Figure 6. Insulin Pumps Picture
Figure 7. Insulin Infuser Picture
Figure 8. Needle-Free Diabetes Care Revenue Market Share by Application in 2019
Figure 9. Consumer Picture
Figure 10. Diagnostic Centers Picture
Figure 11. Hospitals and Clinics Picture
Figure 12. Global Needle-Free Diabetes Care Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Needle-Free Diabetes Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Needle-Free Diabetes Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Needle-Free Diabetes Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Needle-Free Diabetes Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Needle-Free Diabetes Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Needle-Free Diabetes Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Needle-Free Diabetes Care Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Needle-Free Diabetes Care Revenue Market Share in 2019
Figure 21. Global Top 10 Players Needle-Free Diabetes Care Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Needle-Free Diabetes Care Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Needle-Free Diabetes Care Revenue Market Share by Regions (2015-2020)
Figure 25. Global Needle-Free Diabetes Care Revenue Market Share by Regions in 2018
Figure 26. North America Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 27. Europe Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 29. South America Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 31. North America Needle-Free Diabetes Care Revenue Market Share by Countries (2015-2020)
Figure 32. North America Needle-Free Diabetes Care Revenue Market Share by Countries in 2019
Figure 33. USA Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 34. Canada Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 36. Europe Needle-Free Diabetes Care Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Needle-Free Diabetes Care Revenue Market Share by Countries in 2019
Figure 38. Germany Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 39. UK Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 40. France Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 41. Russia Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 42. Italy Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Needle-Free Diabetes Care Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Needle-Free Diabetes Care Revenue Market Share by Countries in 2019
Figure 45. China Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 46. Japan Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 47. Korea Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 48. India Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 50. South America Needle-Free Diabetes Care Revenue Market Share by Countries (2015-2020)
Figure 51. South America Needle-Free Diabetes Care Revenue Market Share by Countries in 2019
Figure 52. Brazil Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Needle-Free Diabetes Care Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Needle-Free Diabetes Care Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 57. UAE Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Needle-Free Diabetes Care Revenue and Growth Rate (2015-2020)
Figure 60. Global Needle-Free Diabetes Care Revenue Share by Type (2015-2020)
Figure 61. Global Needle-Free Diabetes Care Revenue Share by Type in 2019
Figure 62. Global Needle-Free Diabetes Care Market Share Forecast by Type (2021-2025)
Figure 63. Global Insulin Patches Revenue Growth Rate (2015-2020)
Figure 64. Global Jet Injectors Revenue Growth Rate (2015-2020)
Figure 65. Global Insulin Pens Revenue Growth Rate (2015-2020)
Figure 66. Global Insulin Pumps Revenue Growth Rate (2015-2020)
Figure 67. Global Insulin Infuser Revenue Growth Rate (2015-2020)
Figure 68. Global Needle-Free Diabetes Care Revenue Share by Application (2015-2020)
Figure 69. Global Needle-Free Diabetes Care Revenue Share by Application in 2019
Figure 70. Global Needle-Free Diabetes Care Market Share Forecast by Application (2021-2025)
Figure 71. Global Consumer Revenue Growth Rate (2015-2020)
Figure 72. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 74. Global Needle-Free Diabetes Care Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Needle-Free Diabetes Care Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Needle-Free Diabetes Care Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Needle-Free Diabetes Care Revenue Market Forecast (2021-2025)
Figure 78. Europe Needle-Free Diabetes Care Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Needle-Free Diabetes Care Revenue Market Forecast (2021-2025)
Figure 80. South America Needle-Free Diabetes Care Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Needle-Free Diabetes Care Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
糖尿病インスリンポンプの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Diabetes Insulin Pumps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…- 糖尿病インスリンペンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diabetes Insulin Pen market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetes Insulin Pen mar…
- ニードルフリーインジェクターの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Needle Free Injectior market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Needle Free Injectior m…
- 糖尿病用治療装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Diabetes Treatment Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- インスリン送達デバイスの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Insulin Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.6% in the forecast period of 2020 to 2025 and will expected to reach USD 12420 million by 2025, from USD 10790 million in 2019. The Insulin Deliv…